Medicine Regeneron - Search News

Order byBest matchMost fresh

Regeneron to acquire 23andMe assets for $256 million

Drugmaker Regeneron to acquire 23andMe out of bankruptcy

The pharmaceutical giant plans to continue offering 23andMe’s DNA testing service and pledged to adopt its privacy practices to protect customer data.

Industry Leaders Magazine · 2h

Regeneron Acquires 23andMe for $256M Amid Bankruptcy

TMCnet · 1d

Regeneron, A Leading U.S. Biotechnology Company, to Acquire 23andMe in Court-Supervised Sale

· 17h

23andMe to Be Bought by Biotech Company for $256 Million

Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer consumer DNA testing services.

· 21h

Regeneron agrees to buy bankrupt 23andMe

· 1d

Biotechnology Company Regeneron to Buy 23andMe for $256 million

· 1d

Biotechnology company Regeneron buying 23andMe for $256 million

Regeneron said Monday that it will comply with 23andMe’s privacy policies and applicable law, process all customer personal data in accordance with the consents, privacy policies and statements, terms...

· 1d

Regeneron to buy bankrupt DNA testing firm 23andMe for $256 million

· 17h

Genetic Data From 23andMe Ends Up With This Company In $256 Million Deal

Regeneron to buy bankrupt DNA testing firm 23andMe

Digest more

· 1d · on MSN

23andMe sells its most valuable asset. Regeneron promises keep your DNA private.

Regeneron said Monday it will “prioritize the privacy, security and ethical use” of the personal DNA data from about 15 million people in a $256 million deal to acquire assets of bankrupt 23andMe Holding Co.

CNET on MSN · 17h

Can I Delete My 23andMe DNA? Everything to Know as Firm Sells to Regeneron

· 1d

Regeneron agrees to buy bankrupt 23andMe, promises ethical use of customers' DNA data

· 1d

Struggling DNA testing firm 23andMe to be bought for $256m

23andMe says it has entered into an agreement to be acquired by Regeneron Pharmaceuticals for $256m (£192m).

· 22h

23andMe (and Your Genetic Data) Sold to Regeneron in Bankruptcy Auction

· 1d

Bankrupt DNA testing company 23andMe to be bought by Regeneron

Rolling Out1d

The fall of 23andMe and what it means for your DNA

The fall of 23andMe raises privacy concerns as Regeneron buys its genetic database for $256M after bankruptcy.

Information Age12h

Biotech buys bankrupt DNA data firm 23andMe for $400m

Pharmaceutical giant Regeneron has promised to prioritise the “ethical use” of the sequenced DNA data of more than 15 million former customers of bankrupt DNA testing firm 23andMe, which Regeneron has agreed to acquire for $400 million ($US256m).

Mirage News2h

AI Tool Sorts Cancer Patients by Likely Outcomes

A new artificial intelligence-based method accurately sorts cancer patients into groups that have similar characteristics before treatment and similar

75th Annual Regeneron International Science and Engineering Fair Awards Teen Scientists from Around the World More Than $9 Million in 2025 Competition

Regeneron Pharmaceuticals, Inc. and Society for Science (the Society) announced that Adam Kovalčík, 19, of Dulovce, Slovakia, won the $100,000 George D. Yancopoulos Innovator Award at the 75th Regeneron International Science and Engineering Fair (Regeneron ISEF),

Regeneron Continues To Regenerate Its Drug Pipeline, While Keeping Leverage Down

Regeneron earns a buy rating with strong profit margins, low debt, and growth potential. Discover why shares may see a 39% rise in 3 years.